(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/crwe_tech.jpg

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

ad2

http://crweworld.com/assets/images/ad/ad4.png

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com

ad5

http://crweworld.com/assets/images/ad/Pathology_Laboratories.png

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

www.QuestDiagnostics.com






Latest News Releases From The Newsroom

Nivalis Therapeutics and Alpine Immune Sciences Agree to Combine

April 18th, 2017

- Plan to Accelerate Development of Novel Immunotherapies Focused on Inflammation and Immuno-Oncology - - Combined Company Well Capitalized with $90 Million in Funding to Advance Discovery and Development - - Existing Investors OrbiMed Advisors. Read more

Seanergy Maritime Holdings Corp. Announces Time Charter Contract for One of its Capesize Vessels

April 18th, 2017

Athens, Greece / CRWE PRESS RELEASE / April 18, 2017 - Seanergy Maritime Holdings Corp. (the "Company" or "Seanergy") ( NASDAQ : SHIP ), announced today that it has entered into a time charter contract ("T/C") with a major European chartere. Read more

FBI Renews Contract with Inpixon Federal

April 18th, 2017

PALO ALTO, Calif. / CRWE PRESS RELEASE / April 18, 2017 – Inpixon (NASDAQ: INPX), a leading indoor positioning and data analytics company, today announced that subsidiary, Inpixon Federal, has been awarded a second option year re. Read more

Fortuna reports production of 2.0 million ounces of silver and 13,200 ounces of gold for first quarter 2017

April 18th, 2017

Vancouver, British Columbia / CRWE PRESS RELEASE / April 18, 2017 - Fortuna Silver Mines, Inc. (NYSE: FSM) (TSX: FVI) is pleased to announce first quarter 2017 production results from its two operating mines in Latin America, the San Jose Mine i. Read more

Westport Fuel Systems Announces the Signing of a Definitive Agreement to Sell its APU Assets for USD$70 million

April 17th, 2017

Sale in-line with previously announced portfolio review VANCOUVER, BC / CRWE PRESS RELEASE / April 17, 2017 - Westport Fuel Systems Inc. (“Westport Fuel Systems”) (TSX:WPRT / Nasdaq:WPRT) today announced that it has entered into a. Read more

Chelyabinsk Metallurgical Plant Export Project Wins State Support

April 17th, 2017

Moscow, Russia / CRWE PRESS RELEASE / April 17, 2017 - Mechel PAO (MICEX: MTLR, NYSE: MTL), one of the leading Russian mining and metals companies, reports that the Expert Council of Russia’s Industry and Trade Ministry’s Industrial . Read more

Norsat announces receipt of unsolicited, non-binding proposal from Privet Fund Management LLC

April 17th, 2017

Vancouver, British Columbia / CRWE PRESS RELEASE / April 17, 2017 - Norsat International Inc. (“Norsat” or the “Company”) (TSX: NII and NYSE MKT: NSAT), a provider of unique and customized communication solutions for remo. Read more

Puma Biotechnology Announces FDA Advisory Committee to Review Neratinib for the Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer

April 17th, 2017

LOS ANGELES, Calif. / CRWE PRESS RELEASE / April 17, 2017 - Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has scheduled the New Drug Application (NDA) for n. Read more

CASI Pharmaceuticals Reports On Enrollment Status Of ENMD-2076 Phase 2 Study In Triple-Negative Breast Cancer

April 16th, 2017

ROCKVILLE, Md. / CRWE PRESS RELEASE / April 14, 2017 - CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, reported today that along with the inv. Read more

Abbott and Alere Amend Terms of Merger Agreement

April 16th, 2017

ABBOTT PARK, Ill. and WALTHAM, Mass. / CRWE PRESS RELEASE / April 14, 2017 - Abbott (NYSE: ABT) and Alere Inc. (NYSE: ALR) announced today that the companies have agreed to amend the existing terms of their agreement for Abbott's acquisition of A. Read more